Viewing Study NCT01409161


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2025-12-27 @ 9:58 PM
Study NCT ID: NCT01409161
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2011-08-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module